HPV-Related Oropharyngeal Cancer: The Importance of Early Detection & Prevention
AHNS Educational Series: Presented by the AHNS Cancer Prevention and Survivorship/Supportive Care/Rehabilitation Services In Partnership with the Head and Neck Cancer Alliance
Wednesday July, 20, 2022 at 7:00 PM EST
This session is an hour and complimentary for all!
The AHNS gratefully acknowledges the generous educational grant in support of this activity from Roche.
Moderator:
Ann Gillenwater, MD– AHNS Cancer Prevention Service Vice-Chair
Panelists:
Laura Dooley, MD – AHNS Cancer Prevention Service Member
Warren Swegal, MD – AHNS Survivorship/Supportive Care/Rehabilitation Service Member
Kristin Oliver, MD– Pediatrician
Michael Murphy –Survivor, Head and Neck Cancer Alliance Ambassador
At the end of this one-hour webinar, participants will be able to:
1. Identify the current trends in the epidemiology of HPV-related oropharyngeal cancer
2. Recognize the common clinical presentation of HPV-related oropharyngeal cancer
3. Distinguish the short and long-term side effects that come with head and neck cancer treatment
4. Articulate current barriers to population-based screening for HPV-related oropharyngeal cancer, thus emphasizing the importance of primary prevention
5. Outline the current indications for HPV-vaccination and the role it plays in prevention of HPV-related cancers.
Register Here Now!
